Clinical Trial Update: Functional MRI Evaluation of the Effect of Citalopram in Autism Spectrum Disorders [Phase 1]

View source ↗

Summary

A Phase 1 trial using functional MRI to evaluate the effect of citalopram in autism spectrum disorder has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• Citalopram (Citalopram hydrobromide)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Autism Spectrum Disorders | Phase 1 | Status: COMPLETED